Conmed (CNMD) Share-based Compensation (2010 - 2026)

Conmed has reported Share-based Compensation for 17 years, with the latest figure at $5.5 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 60.31% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at $19.9 million (down 39.99% YoY), and the FY2025 full-year result was $28.3 million, up 10.55% from the prior year.
• Share-based Compensation for Q1 2026 stood at $5.5 million, up from $4.9 million in the prior quarter.
• The five-year high for Share-based Compensation was $13.9 million in Q1 2025, with the low at $4.5 million in Q1 2022.
• Historically, Share-based Compensation has averaged $6.2 million across 5 years, with a median of $5.8 million in 2022.
• Annual changes were most pronounced in 2025 — Share-based Compensation surged 122.16% — and 2026, when it tumbled 60.31%.
• Conmed's Share-based Compensation stood at $5.8 million in 2022, then rose by 2.88% to $5.9 million in 2023, then increased by 5.76% to $6.3 million in 2024, then decreased by 21.01% to $4.9 million in 2025, then rose by 11.2% to $5.5 million in 2026.
• The last three Share-based Compensation figures came in at $5.5 million (Q1 2026), $4.9 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.